Nitazoxanide for cryptosporidial infection in Crohn's disease.
Smith
S
S
Shaw
J
J
Nathwani
D
D
D000328:Adult; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D003092:Colitis / Q000188:drug therapy; D003424:Crohn Disease / Q000150:complications*; D003457:Cryptosporidiosis / Q000188:drug therapy*; D016785:Cryptosporidium parvum; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy; D009574:Nitro Compounds; D009894:Opportunistic Infections / Q000188:drug therapy*; D013844:Thiazoles / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D009574:Nitro Compounds; D013844:Thiazoles; C041747:nitazoxanide